• Profile
Close

Cefazolin monotherapy versus cefazolin plus aminoglycosides for antimicrobial prophylaxis of type III open fractures

American Journal of Therapeutics Jan 13, 2021

Patanwala AE, Radosevich JJ, Meshay I, et al. - In this study, cefazolin monotherapy vs cefazolin plus aminoglycoside therapy for prophylaxis of type III open fractures was compared in trauma patients. Researchers performed a multicenter, retrospective, cohort study in 3 academic medical centers in the United States. Between January 2014 and September 2016, they included consecutive adult trauma patients with type III open fractures. Individuals were classified into 2 groups: cefazolin monotherapy vs cefazolin plus an aminoglycoside. The study cohort included a total of 134 patients.It was shown that in trauma patients, cefazolin monotherapy may be appropriate for antimicrobial prophylaxis of type III open fractures.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay